Biogen Inc. (BIIB)

USD 146.79

(-2.56%)

Total Assets Summary of Biogen Inc.

  • Biogen Inc.'s latest annual total assets in 2023 was 26.84 Billion USD , up 9.33% from previous year.
  • Biogen Inc.'s latest quarterly total assets in 2024 Q3 was 28.31 Billion USD , up 5.63% from previous quarter.
  • Biogen Inc. reported annual total assets of 24.55 Billion USD in 2022, up 2.83% from previous year.
  • Biogen Inc. reported annual total assets of 23.87 Billion USD in 2021, down -3.01% from previous year.
  • Biogen Inc. reported quarterly total assets of 26.56 Billion USD for 2024 Q1, down -1.03% from previous quarter.
  • Biogen Inc. reported quarterly total assets of 28.31 Billion USD for 2024 Q3, up 5.63% from previous quarter.

Annual Total Assets Chart of Biogen Inc. (2023 - 1989)

Historical Annual Total Assets of Biogen Inc. (2023 - 1989)

Year Total Assets Total Assets Growth
2023 26.84 Billion USD 9.33%
2022 24.55 Billion USD 2.83%
2021 23.87 Billion USD -3.01%
2020 24.61 Billion USD -9.6%
2019 27.23 Billion USD 7.69%
2018 25.28 Billion USD 6.92%
2017 23.65 Billion USD 3.39%
2016 22.87 Billion USD 17.29%
2015 19.5 Billion USD 36.24%
2014 14.31 Billion USD 20.68%
2013 11.86 Billion USD 17.11%
2012 10.13 Billion USD 11.94%
2011 9.04 Billion USD 11.83%
2010 8.09 Billion USD -5.37%
2009 8.55 Billion USD 0.86%
2008 8.47 Billion USD -1.74%
2007 8.62 Billion USD 0.89%
2006 8.55 Billion USD 2.22%
2005 8.36 Billion USD -8.72%
2004 9.16 Billion USD -3.56%
2003 9.5 Billion USD 373.54%
2002 2 Billion USD 16.61%
2001 1.72 Billion USD 20.2%
2000 1.43 Billion USD 12.04%
1999 1.27 Billion USD 38.2%
1998 924.71 Million USD 13.63%
1997 813.82 Million USD 28.25%
1996 634.57 Million USD 35.25%
1995 469.2 Million USD 24.17%
1994 377.86 Million USD 5.84%
1993 357 Million USD 14.72%
1992 311.2 Million USD 22.96%
1991 253.1 Million USD 59.68%
1990 158.5 Million USD 9.16%
1989 145.2 Million USD 79.48%

Peer Total Assets Comparison of Biogen Inc.

Name Total Assets Total Assets Difference
Amgen Inc. 97.15 Billion USD 72.369%
AstraZeneca PLC 101.11 Billion USD 73.452%
Gilead Sciences, Inc. 62.12 Billion USD 56.789%
MIRA Pharmaceuticals, Inc. 4.93 Million USD -544149.574%
Scilex Holding Company 101.3 Million USD -26397.942%
Scilex Holding Company 101.3 Million USD -26397.942%